Thank Todd. you,
the million, over increase $XX.X quarter. the Our prior XX.X% a quarter year revenue for was
versus approximately led was prior the growth case addition due volumes, Our novo four which increase year primarily in is by centers de to base. the of XX%
we XXXX, the at quarter XX, the operated of March of centers XXXX. versus first XX X end of As
term. Our over for $XXX X.X% to to quarter a average revenue fourth year's our a $XX,XXX quarter, for driven this expect was prior the near target range increase was approximately quarter by $XX,XXX, we mix. and over increase the within sustain range the per case of This the $XX,XXX and primarily procedure
related Our growth for clinical-related cost period the last quarter costs cost to of of acquisition addition the in XX.X% was is XX.X% our $X,XXX percentage same customer case. revenue was a The increase versus as services to of primarily our and per support the year.
our XXX margin on For the prior and adjusted points was quarter, basis, which sequential discussed. decline due margin million have of our our by EBITDA quarter, year previously increased adjusted XXX to XX.X%, the we in And versus adjusted a basis EBITDA increase expense a was that EBITDA $XX.X points. growth was basis
liquidity strong. very position Our be to continues
$XX.X Our of and XX, undrawn. revolver XXXX remains million $X was cash as our million position March
of Our gross under ratio agreement $XX.X credit leverage debt quarter times. end outstanding X.X was was our million the our at calculated as and the
XX%. and for represents we new cash And an conversion primarily activities of approximately Cash the $X.X million which XX% quarter of a EBITDA million, the $X.X ratio ratio from EBITDA approximately conversion adjusted year. flow related adjusted expect to centers was had We for of opening an full we $XXX,XXX. use operations continue financing to invested from of
measure measure with useful of We share quarter fourth the earnings information consistent $X.XX. Additionally, net non-GAAP share of release, in diluted EBITDA. of represents per earnings provided items the we this income believe our the quarter a investors reflecting per highlighting to used calculating by adjusted selected adjusted for impact
We healthy remain on cash flow free track in XXXX. for generation
will to business our during such novo fund growth the We technology cash innovations. adding centers year primary and continue as be the investments of to expect driving de flow uses for
sheet throughout expect to to positioning We the rest shareholder the year, our increase continue us strengthen of to also value. balance
morning, we confirming $XXX increase XXXX. representing XX% This to range $XXX XXXX our XX% to over an revenue million, million of guidance are
to expect to year-over-year novo de from revenue contributions continue the magnitude We our growth. of centers drive
next this cases at Orange previously cases month past scheduled Austin performing County Center our begin As location started to at week. our we and we discussed, are performing
London that cases in in open we begin paid starting Rollins to will As Dr. to scheduling center and and we pleased report are Todd June. mentioned, approved is our
Our and remaining are total scheduled will us give five center open which quarter, San third Raleigh Jose centers locations, a the two added to new late of in XXXX. for
and EBITDA EBITDA guidance. which XX% We both $XX are adjusted confirming approximately midpoint growth to XXXX of to XX% of margins million guidance also at range our and XX% represents revenue of of $XX year-over-year million, the
to patterns the the will expect in We quarter expect we similar of that XXXX. half strongest XXXX the our the quarter, to back while be seasonal back of half of second be
call the the questions. turn over I'll With that, some for operator Operator? to